blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3946302

EP3946302 - METHODS AND COMPOSITIONS FOR TREATING PAIN [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.01.2022
Database last updated on 28.09.2024
FormerThe international publication has been made
Status updated on  14.11.2020
Most recent event   Tooltip28.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Apkarian Technologies LLC
150 W Eugene Street Nr.29
Chicago, IL 60614 / US
[2022/06]
Inventor(s)01 / APKARIAN, A., Vania
150 W. Eugenie Street, 29
Chicago, IL 60614 / US
[N/P]
Former [2022/06]01 / APKARIAN, A., Vania
Chicago, IL 60614 / US
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2022/06]
Application number, filing date20802537.908.05.2020
[2022/06]
WO2020US32142
Priority number, dateUS201962845782P09.05.2019         Original published format: US 201962845782 P
[2022/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020227646
Date:12.11.2020
Language:EN
[2020/46]
Type: A1 Application with search report 
No.:EP3946302
Date:09.02.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application.
[2022/06]
Search report(s)International search report - published on:US12.11.2020
(Supplementary) European search report - dispatched on:EP01.12.2022
ClassificationIPC:A61K31/167, A61K31/192, A61K31/198, A61K31/428
[2022/06]
CPC:
A61K45/06 (EP); A61K31/167 (US); A61K31/192 (EP,US);
A61K31/198 (EP,US); A61K31/425 (US); A61K31/428 (EP);
A61P25/00 (EP); A61P29/00 (US) (-)
C-Set:
A61K31/192, A61K2300/00 (EP);
A61K31/198, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/06]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR SCHMERZBEHANDLUNG[2022/06]
English:METHODS AND COMPOSITIONS FOR TREATING PAIN[2022/06]
French:PROCÉDÉS ET COMPOSITIONS POUR LE TRAITEMENT DE LA DOULEUR[2022/06]
Entry into regional phase05.11.2021National basic fee paid 
05.11.2021Search fee paid 
05.11.2021Designation fee(s) paid 
05.11.2021Examination fee paid 
Examination procedure05.11.2021Examination requested  [2022/06]
30.06.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.05.2022Renewal fee patent year 03
29.11.2023Renewal fee patent year 04
28.05.2024Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.202304   M06   Fee paid on   29.11.2023
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2005107467  (DESCARTES THERAPEUTICS INC [US], et al) [X] 1 * the whole document *;
 [A]WO2010010136  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-15* the whole document *;
 [A]WO2014025638  (MYLAN INC [US]) [A] 1-15 * the whole document * * paragraphs [0007] , [0015]; claims 1,9,11 *;
 [X]US2017143681  (APKARIAN A VANIA [US]) [X] 1-15 * the whole document * * paragraphs [0095] - [0097] * * paragraphs [0111] - [0112] * * examples 5-14 * * claims 1-66 *;
 [A]  - HOLMAN A J ET AL, "A Randomized Double Blind Placebo Controlled Trial of Pramipexole, a Dopamine Agonist, in Patinets with Fibromyalgia Receiving Concimitant Medication", ARTHRITIS & RHEUMATISM, WILEY INTERSCIENCE, US, (20050101), vol. 52, no. 8, doi:10.1002/ART.21191, ISSN 0004-3591, pages 2495 - 2506, XP002454911 [A] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1002/art.21191
International search[A]US2010029723  (QUIK MARYKA [US], et al) [A] 1-7, 225-395, 424* entire document *;
 [A]US2011230513  (LAMENSDORF ITSCHAK [IL], et al) [A] 1-7, 225-395, 424 * entire document *;
 [Y]US8946152  (GILL STEVEN S [GB], et al) [Y] 388, 390-395 * entire document *;
 [A]US2015301030  (EGGAN KEVIN C [US], et al) [A] 1-7, 225-395, 424 * entire document *;
 [XY]US2017143681  (APKARIAN A VANIA [US]) [X] 1-7, 225-387, 424 * entire document * [Y] 388, 390-395
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.